233 related articles for article (PubMed ID: 38701251)
1. β-Thalassemia gene editing therapy: Advancements and difficulties.
Hu J; Zhong Y; Xu P; Xin L; Zhu X; Jiang X; Gao W; Yang B; Chen Y
Medicine (Baltimore); 2024 May; 103(18):e38036. PubMed ID: 38701251
[TBL] [Abstract][Full Text] [Related]
2. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
Eid A; Mahfouz MM
Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
[TBL] [Abstract][Full Text] [Related]
3. Construction and Evaluation of Zinc Finger Nucleases.
Ochiai H; Yamamoto T
Methods Mol Biol; 2023; 2637():1-25. PubMed ID: 36773134
[TBL] [Abstract][Full Text] [Related]
4. Gene editing and CRISPR in the clinic: current and future perspectives.
Hirakawa MP; Krishnakumar R; Timlin JA; Carney JP; Butler KS
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32207531
[TBL] [Abstract][Full Text] [Related]
5. Research on genodermatoses using novel genome-editing tools.
Lehmann J; Seebode C; Emmert S
J Dtsch Dermatol Ges; 2017 Aug; 15(8):783-789. PubMed ID: 28622433
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases.
Rasoulinejad SA; Maroufi F
Mol Biotechnol; 2021 Sep; 63(9):768-779. PubMed ID: 34057656
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas-based gene editing in therapeutic strategies for beta-thalassemia.
Zeng S; Lei S; Qu C; Wang Y; Teng S; Huang P
Hum Genet; 2023 Dec; 142(12):1677-1703. PubMed ID: 37878144
[TBL] [Abstract][Full Text] [Related]
8. 'Old' genome editors might treat mitochondrial diseases.
Leslie M
Science; 2018 Sep; 361(6409):1302. PubMed ID: 30262479
[No Abstract] [Full Text] [Related]
9. Genome editing in plants: Advancing crop transformation and overview of tools.
Shah T; Andleeb T; Lateef S; Noor MA
Plant Physiol Biochem; 2018 Oct; 131():12-21. PubMed ID: 29754773
[TBL] [Abstract][Full Text] [Related]
10. Genome Editing of Rat.
Kaneko T
Methods Mol Biol; 2023; 2637():223-231. PubMed ID: 36773150
[TBL] [Abstract][Full Text] [Related]
11. Target-specific gene delivery in plant systems and their expression: Insights into recent developments.
Nandy D; Maity A; Mitra AK
J Biosci; 2020; 45():. PubMed ID: 32020912
[TBL] [Abstract][Full Text] [Related]
12. Basics of genome editing technology and its application in livestock species.
Petersen B
Reprod Domest Anim; 2017 Aug; 52 Suppl 3():4-13. PubMed ID: 28815851
[TBL] [Abstract][Full Text] [Related]
13. INDEL detection, the 'Achilles heel' of precise genome editing: a survey of methods for accurate profiling of gene editing induced indels.
Bennett EP; Petersen BL; Johansen IE; Niu Y; Yang Z; Chamberlain CA; Met Ö; Wandall HH; Frödin M
Nucleic Acids Res; 2020 Dec; 48(21):11958-11981. PubMed ID: 33170255
[TBL] [Abstract][Full Text] [Related]
14. Recent Progress in Gene Therapy and Other Targeted Therapeutic Approaches for Beta Thalassemia.
Hamed EM; Meabed MH; Aly UF; Hussein RRS
Curr Drug Targets; 2019; 20(16):1603-1623. PubMed ID: 31362654
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9: an advanced tool for editing plant genomes.
Samanta MK; Dey A; Gayen S
Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
[TBL] [Abstract][Full Text] [Related]
16. Non-viral delivery of genome-editing nucleases for gene therapy.
Wang M; Glass ZA; Xu Q
Gene Ther; 2017 Mar; 24(3):144-150. PubMed ID: 27797355
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas9 Technology for the Creation of Biological Avatars Capable of Modeling and Treating Pathologies: From Discovery to the Latest Improvements.
Nasrallah A; Sulpice E; Kobaisi F; Gidrol X; Rachidi W
Cells; 2022 Nov; 11(22):. PubMed ID: 36429042
[TBL] [Abstract][Full Text] [Related]
18. Genome Editing for the Understanding and Treatment of Inherited Cardiomyopathies.
Nguyen Q; Lim KRQ; Yokota T
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979133
[TBL] [Abstract][Full Text] [Related]
19. Application and development of genome editing technologies to the Solanaceae plants.
Yamamoto T; Kashojiya S; Kamimura S; Kameyama T; Ariizumi T; Ezura H; Miura K
Plant Physiol Biochem; 2018 Oct; 131():37-46. PubMed ID: 29523384
[TBL] [Abstract][Full Text] [Related]
20. [Advances in gene therapy for β-thalassemia and hemophilia based on the CRISPR/Cas9 technology].
Bao LW; Zhou YY; Zeng FY
Yi Chuan; 2020 Oct; 42(10):949-964. PubMed ID: 33229321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
